What Is Immunodeficiency Infusion Therapy
Immunodeficiency infusion therapy is the cornerstone of treatment for patients living with primary and secondary immune deficiency disorders — conditions in which the immune system is unable to produce sufficient antibodies to protect the body against infections and disease.
KabaFusion is one of the nation’s most specialised providers of immunodeficiency infusion therapy — delivering expert IVIG and SCIG treatment to patients in the comfort and safety of their own homes with the highest standard of clinical care.
Understanding Immunodeficiency Disorders
Immunodeficiency disorders are conditions in which the immune system’s ability to function normally is impaired. This can be due to a genetic defect — known as primary immunodeficiency — or as a result of another medical condition, treatment, or environmental factor — known as secondary immunodeficiency.
Primary immunodeficiency diseases are a group of more than 450 rare chronic disorders in which part of the body’s immune system is missing or does not function normally. The most common primary immunodeficiency diseases include Common Variable Immunodeficiency — CVID. X-Linked Agammaglobulinemia — XLA. Specific Antibody Deficiency. Hyper IgM Syndrome.
Each of these conditions creates a specific pattern of immune system failure that immunodeficiency infusion therapy is designed to address — replacing the missing or deficient immunoglobulins that the patient’s immune system cannot produce on its own.
Immunodeficiency Conditions Treated at KabaFusion
KabaFusion’s immunodeficiency infusion therapy programme covers a comprehensive range of primary and secondary immune deficiency conditions. Patients referred to KabaFusion receive a personalised immunodeficiency infusion care plan developed in close collaboration with their treating immunologist.
Conditions treated through KabaFusion’s immunodeficiency infusion programme include Common Variable Immunodeficiency — CVID. X-Linked Agammaglobulinemia — XLA. Specific Antibody Deficiency — SAD. Hyper IgM Syndrome. Selective IgA Deficiency with recurrent infections. Secondary immunodeficiency due to hematologic malignancies. Secondary immunodeficiency related to immunosuppressive therapy. Good Syndrome — immunodeficiency with thymoma.
If your immunologist has recommended immunodeficiency infusion therapy for any of these conditions, KabaFusion’s expert home care programme may be exactly the right solution for your treatment needs.
IVIG Therapy for Immunodeficiency Infusion — How It Works
IVIG therapy is the standard of care for most primary immunodeficiency diseases and a central component of KabaFusion’s immunodeficiency infusion programme. IVIG provides the missing immunoglobulins — antibodies — that a patient’s immune system cannot produce on its own, reducing the frequency and severity of infections and improving overall health and quality of life.
IVIG is administered intravenously over several hours — typically every 3 to 4 weeks — depending on the patient’s IgG levels, clinical condition, and physician recommendations. KabaFusion works with each patient’s immunologist to select the most appropriate IVIG product and dose for their specific immunodeficiency infusion requirements.
KabaFusion’s clinical pharmacists bring deep expertise to every immunodeficiency infusion programme — carefully calibrating IVIG dosing, managing infusion rate titration, and coordinating every aspect of therapy delivery to ensure optimal outcomes and patient safety throughout the immunodeficiency infusion process.
SCIG Therapy — Flexible Immunodeficiency Infusion for Independent Patients
Subcutaneous immunoglobulin — SCIG — therapy is an increasingly popular alternative to IVIG for immunodeficient patients seeking greater flexibility and independence in their immunodeficiency infusion schedule.
SCIG therapy is administered through a small needle placed just under the skin — typically once a week or more frequently in smaller doses. Many patients appreciate SCIG because it allows for more stable serum IgG levels, requires shorter infusion times, and can often be self-administered at home once training is complete.
KabaFusion provides comprehensive SCIG training, supplies, and ongoing clinical oversight for immunodeficiency infusion patients transitioning to subcutaneous therapy. Our nurses work closely with each patient to ensure they are confident and comfortable with the self-administration process before transitioning to independent SCIG immunodeficiency infusion therapy.
Clinical Excellence in Immunodeficiency Infusion at KabaFusion
KabaFusion’s reputation in immunodeficiency infusion therapy is built on clinical excellence and a genuine commitment to patient outcomes that sets it apart from general home infusion providers.
Our pharmacists and nurses are specifically trained in the requirements of immunoglobulin therapy — including rate titration, premedication protocols, and the recognition and management of adverse reactions unique to immunodeficiency infusion patients.
KabaFusion maintains meticulous records of each patient’s infusion history, IgG trough levels, infection frequency, and clinical response — sharing this data regularly with the treating immunologist to support ongoing immunodeficiency infusion treatment optimisation. This proactive approach to physician communication ensures that every patient’s immunodeficiency infusion programme remains precisely calibrated to their evolving clinical needs.
Access and Insurance Coverage for Immunodeficiency Infusion Therapy
KabaFusion accepts Medicare, Medicaid, and most commercial insurance plans for immunodeficiency infusion therapy. Our benefits specialists work diligently to secure and maintain coverage for every immunodeficiency infusion patient — handling prior authorisations, medical necessity documentation, and appeals on behalf of each patient.
KabaFusion also connects patients with manufacturer patient assistance programmes when needed — ensuring that no patient is denied access to the immunodeficiency infusion therapy they need due to financial barriers.
Contact KabaFusion for Immunodeficiency Infusion Today
KabaFusion is a nationally recognised leader in expert home-based immunodeficiency infusion therapy. Our specialist clinical team delivers personalised IVIG and SCIG immunodeficiency infusion treatment for primary and secondary immune deficiency conditions — with 24/7 clinical support across the United States.
Phone: 888.204.9304 Website: www.kabafusion.com Email: info@KabaFusion.com Quick Referral: kabafusion.com/easy-patient-referral-form